Allocation of Non-Commercial CAB for PrEP Supply in Low- and Middle-Income Countries, 2023-2025

Embed Download PDF Download Image

Malaysia, Nigeria, Peru, Zambia, and the European Medicines Agency have approved CAB for PrEP; ViiV also made submissions in Canada, Colombia, and the United Kingdom. There are now 13 regulatory approvals and 15 additional submissions that are pending.

Excerpted from PxWire Volume 13, Issue 4.